SDZXF:OTCMKTS
Sandoz Group AG
80,40 $
arrow_downward
-2,06%(-1,69) 1 d.
14. sept., 16:00:00 GMT-4 · USD
search
Visi simboli
1 d.
5 d.
1 m.
6 m.
Š.g.
1 g.
5 g.
Maks.
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: SDZXF…
Atvērt
80,40 $
Augsta
80,40 $
Zema
80,40 $
Tirgus kapitalizācija
28,98 mljrd.
Vid. apjoms
58,00
Apjoms
2,00 tūkst.
Augstākā 52 ned.
94,55 $
Zemākā 52 ned.
55,50 $
Apgrozībā esošās akcijas
440,00 milj.
Darbinieku skaits
20 tūkst.
Atvērt
80,40 $
Augsta
80,40 $
Zema
80,40 $
Tirgus kapitalizācija
28,98 mljrd.
Vid. apjoms
58,00
Apjoms
2,00 tūkst.
Augstākā 52 ned.
94,55 $
Zemākā 52 ned.
55,50 $
Apgrozībā esošās akcijas
440,00 milj.
Darbinieku skaits
20 tūkst.
Profils
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
Par “Sandoz Group AG”
ĢenerāldirektorsRichard Saynor
Darbinieki20 tūkst.
Dibināšanas datums1886
Galvenais birojs-
Sektors-
Tīmekļa vietnesandoz.com